Examination of adenosine receptor-mediated relaxation of the pig coronary artery

Clinical and Experimental Pharmacology and Physiology

Volumn 26, Issue 5-6, 1999, Pages 438-443

  Lew, Michael J ^a   Kao, Sheau W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adenosine receptors; Functional antagonism; Pig coronary artery; Preconstriction; Vasodilatation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 6 N (2 HYDROXYCYCLOPENTYL)ADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; POTASSIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CONCENTRATION RESPONSE; CORONARY ARTERY DILATATION; DRUG POTENCY; ENDOTHELIUM INJURY; NONHUMAN; POTASSIUM TRANSPORT; RECEPTOR UPREGULATION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; SWINE; THEOBROMINE; VASODILATION; VASODILATOR AGENTS;

EID: 0032982656     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.1999.03054.x     Document Type: Article

References (38)

1. 1. Berne RM. The role of adenosine in the regulation of coronary blood flow. Circ. Res. 1980; 47: 807-13.
2. 2. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991; 18: 565-74.
3. 3. Mubagwa K, Mullane K, Flameng W. Role of adenosine in the heart and circulation. Cardiovasc. Res. 1996; 32: 797-813.
4. 4. Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. 1929; 68: 213-37.
5. 5. Van Calker D, Muller M, Hamprecht B. Adenosine regulated via two different types of receptors: The accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 1979; 33: 999-1005.
6. 6. Linden J, Tucker AL, Robeva AS, Graber SG, Munshi R. Properties of recombinant adenosine receptors. Drug Dev. Res. 1993; 28: 232-6.
7. 7. Mustafa SJ, Askar AO. Evidence suggesting an Ra-type adenosine receptor in bovine coronary artery. J. Pharmacol. Exp. Ther. 1985; 232: 49-56.
8. 8. Gurden MF, Coates J, Ellis F et al. Functional characterization of three adenosine receptor types. Br. J. Pharmacol. 1993; 109: 693-8.
9. 9. King AD, Milavec-Krizman M, Muller-Schweinitzer E. Characterization of adenosine receptor in porcine coronary arteries. Br. J. Pharmacol. 1990; 100: 483-6.
10. 3H]SCH58261 to coronary artery membranes. Circ. Res. 1996; 79: 1153-60.
11. 2 adenosine receptor in human coronary arteries. Eur. J. Pharmacol. 1988; 151: 483-6.
12. 1-selective adenosine agonist in porcine coronary artery: Involvement of potassium channels. J. Pharmacol. Exp. Ther. 1992; 260: 437-43.
13. 13. Niiya K, Uchida S, Tsuji T, Olsson RA. Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists. J. Pharmacol. Exp. Ther. 1994; 271: 14-19.
14. 14. Abebe W, Makujina SR, Mustafa SJ. Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol. 1994; 266: H2018-25.
15. 15. Lew M, Angus JA. Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol. Sci. 1995; 16: 328-37.
16. 1 adenosine receptor antagonist. Life Sci. 1987; 40: 555-63.
17. 17. Collis MG, Hourani SMO. Adenosine receptor subtypes. Trends Pharmacol. Sci. 1993; 14: 360-6.
18. 18. Doyle MP, Linden J, Duling BR. Nucleoside-induced arteriolar constriction: A mast cell-dependent response. Am. J. Physiol. 1994; 266: H2042-50.
19. 3 receptor activation in rats. Eur. J. Pharmacol. 1996; 298: 293-7.
20. 3 adenosine receptor. Circ. Res. 1996; 78: 627-34.
21. ATP channel involvement in adenosine receptor-mediated dilation of epicardial vessels. Am. J. physiol. 1994; 267: H716-24.
22. 22. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol. Rev. 1990; 70: 761-809.
23. 23. Dart C, Standen NB. Adenosine-activated potassium current in smooth muscle cells isolated from the pig coronary artery. J. Physiol. 1993; 471: 767-86.
24. 24. Wiener HL, Thalody GP. Differential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta. J. Pharmacol. Exp. Ther. 1993; 267: 828-37.
25. 25. Ariens EJ, Simonis AM, Van Rossum JM. The relation between stimulus and effect. In: Ariens EJ (ed.). Molecular Pharmacology, vol. 1. Academic Press, London, 1964; 394-405.
26. 26. Van Den Brink FG. The model of functional interaction: 1. Development and first check of a new model of functional synergism and antagonism. Eur. J. Pharmacol. 1973; 22: 270-8.
27. 27. Lew MJ. Extended concentration response curves used to reflect full agonist efficacies and receptor occupancy-response coupling ranges. Br. J. Pharmacol. 1995; 115: 745-52.
28. 28. Sabouni MH, Ramagopal MV, Mustafa SJ. Adenosine receptor-mediated relaxation in coronary artery: Evidence for a guanyl nucleotide-binding regulatory protein involvement. J. Pharmacol. Exp. Ther. 1989; 251: 943-8.
29. 29. Morgan JP, Perreault CL, Morgan KG. The cellular basis of contraction and relaxation in cardiac and vascular smooth muscle. Am. Heart J. 1991; 121: 961-8.
30. 30. Yamagishi T, Yanagisawa T, Satoh K, Taria N. Relaxant mechanisms of cyclic AMP-increasing agents in porcine coronary artery. Eur. J. Pharmacol. 1994; 251: 253-62.
31. 2+ in porcine coronary artery. Am. J. Physiol. 1996; 270: H134-41.
32. 32. Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J. 1987; 1: 177-85.
33. 33. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation: Implications for vascular function. Circulation 1991; 84: 1457-68.
34. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ. Res. 1992; 70: 612-16.
35. 2+ sensitivity in α-toxin permeabilized rabbit mesenteric artery. Circ. Res. 1992; 71: 951-9.
36. 2 analog (U46619) of calcium dynamics in isolated rat cardiomyocytes. J. Pharmacol. Exp. Ther. 1993; 264: 336-43.
37. 37. Hori M, Sato K, Miyamoto S, Ozaki H, Karaki H. Different pathways of calcium sensitization activated by receptor agonists and phorbol esters in vascular smooth muscle. Br. J. Pharmacol. 1993; 110: 1527-31.
38. 38. Abe F, Mitsui M, Karaki H, Endoh M. Calcium compartments in vascular smooth muscle cells as detected by aequorin signal. Br. J. Pharmacol. 1995; 116: 3000-4.